The most common drug-related adverse events for patients treated with trabectedin were nausea ( @ -LSB- @ % -RSB- of @ ) , decreased appetite ( @ -LSB- @ % -RSB- ) , decreased neutrophil count ( @ -LSB- @ % -RSB- ) , increased alanine aminotransferase ( @ -LSB- @ % -RSB- ) , and decreased white blood cell count ( @ -LSB- @ % -RSB- ) .